Pink Pussycat SENSUAL ENHANCEMENT capsule — Class I drug recall D-0785-2022
Terminated recall by Pink Toyz, reported 2022-04-27, distributed nationwide. Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ing
| Recall number | D-0785-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Pink Toyz, Chatsworth, CA, United States |
| Recall initiated | 2022-03-29 |
| Classified | 2022-04-25 |
| Reported by FDA | 2022-04-27 |
| Terminated | 2024-07-31 |
| Distributed | Nationwide (US) |
| Quantity | 120 blister |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00891875004626 |
| Lot numbers | 2009066 |
| Expiration dates | 2023-09 |
Product
Pink Pussycat SENSUAL ENHANCEMENT capsule, 3000mg, 1-count blister card, Manufactured for: Pink Pussycat Products - Chatsworth, CA 91311, UPC 8 91875 00462 6.
Reason for recall
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0785-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.